ROTHSCHILD & CO ASSET MANAGEMENT US INC. – Horizon Therapeutics Public Limited Company Transaction History
ROTHSCHILD & CO ASSET MANAGEMENT US INC. portfolio value:
$26.53M
portfolio value
ROTHSCHILD & CO ASSET MANAGEMENT US INC. quarter portfolio value change:
-22.40%
quarter
Horizon Therapeutics Public Limited Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.10% | -13.72K shares | -8.75M | $61.89 | 428.70K |
| Q2 2022 | share | Increase | +4.80% | 20.24K shares | -9.13M | $79.76 | 442.43K |
| Q1 2022 | share | Increase | +58.93% | 156.54K shares | 15.79M | $105.21 | 422.18K |
| Q4 2021 | share | Decrease | -1.02% | -2.72K shares | -771K | $108.26 | 265.63K |
| Q3 2021 | share | Decrease | -6.42% | -18.40K shares | 2.54M | $109.54 | 268.36K |
| Q2 2021 | share | Decrease | -33.26% | -142.90K shares | -12.69M | $93.64 | 286.76K |
| Q1 2021 | share | Decrease | -29.14% | -176.68K shares | -4.80M | $92.04 | 429.66K |
| Q4 2020 | share | Decrease | -17.55% | -129.10K shares | -12.77M | $73.15 | 606.34K |
| Q3 2020 | share | Decrease | -18.14% | -162.96K shares | 7.19M | $77.68 | 735.44K |
| Q2 2020 | share | Decrease | -37.45% | -537.82K shares | 7.39M | $55.58 | 898.41K |
| Q1 2020 | share | Decrease | -15.74% | -268.36K shares | -19.16M | $29.62 | 1.43M |
| Q4 2019 | share | Decrease | -8.91% | -166.81K shares | 10.74M | $36.2 | 1.70M |
| Q3 2019 | share | Increase | +10.23% | 173.73K shares | 10.11M | $27.23 | 1.87M |
| Q2 2019 | share | Increase | 0.00% | 1.69M shares | 40.84M | $24.06 | 1.69M |